Souhami 1991.
Methods | RCT 1984‐1986 | |
Participants | 103 (4*) FIGO stage IIIB patients | |
Interventions | CT + RT vs RT CT: CDDP 50mg/m2 BLM 120U VCR 1mg/m2 MMC 10mg/m2. Every 21 days for 3 cycles. RT: 50Gy in 25F over 35 days. Intracavitary 40Gy |
|
Outcomes | Survival Disease‐free survival Loco‐regional diease‐free survival Metastases‐free survival Late toxicity | |
Notes | Treatment comparison 1 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Low risk | A ‐ Adequate |